ZBH · Zimmer Biomet
Orthopedic implants — hips, knees, sports medicine
Risiko 4/10 · LOW-MODERATE RISK · slow-growth medtech · $98.07 ▼ 0.86%Von KI geschrieben
Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren
Kennzahlen
- Price $98.07
- Market cap $18.7B
- P/E (ttm) 23.8
- Div yield 0.98%
- 52-wk range $79.12 – $106.88
- Index rank #404 / —
Wichtigste Risiken
- Growth stays stuck in low single digits as Stryker takes share (Shareholders) — MED
- Hospital and payer pricing pressure on implants (Shareholders) — MED
- Product recalls and orthopedic liability litigation (Customers) — MED
- Restructuring programs that never quite deliver the margin (Shareholders) — LOW
Fazit
Cheap and steady, but a show-me story until growth accelerates — moderate risk, modest reward.
Recherche, keine Anlageberatung.